Tang-Hua Liu
Tang-Hua Liu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Yan-Qing Liu
Department of Painology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3 shared publications - Dong Huang
Department of Painology, The Third Xiangya Hospital of Central South University, Changsha, China
2 shared publications - Lin Wang
Department of Painology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China
2 shared publications - Xian-Guo Liu
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China
2 shared publications - Yan Lu
Department of Painology, Xijing Hospital affiliated to Air Force Medical University, Xi'an, China
2 shared publications - Zhang Baojuan
Department of Painology, The First People's Hospital of Jining, Jining, China
2 shared publications
Latest Publications
- Open Access
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 107-131
A Chinese Guideline for the Diagnosis and Treatment of Chronic LOW Back Pain (2024 Edition)
Background: Low back pain (LBP) is the leading cause of disability worldwide, severely impairing patients' quality of life, consuming substantial healthcare resources, and increasing medical costs while reducing productivity. Low back pain has become the leading cause of disability worldwide and a major global public health issue. Objective: To enhance the ability of diagnosis and treatment for LBP to meet the needs of clinical diagnosis and treatment. Main ideas: Based on high quality evidence based medical research on the diagnosis and treatment of LBP published domestically and internationally between January 2010 and December 2023, the expert group of the Pain Disease Diagnosis and Treatment Special Capacity Enhancement Project of the National Health Commission of China's Capacity Building and Continuing Education Centerhas formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of LBP. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common chronic specific low back pain (cSLBP) and chronic non-specific low back pain (cNSLBP). Conclusion: LBP is characterized by high prevalence, significant disability rates, and frequent recurrence, imposing substantial burdens on individuals, families, and society. For patients, improving understanding of cLBP, practicing effective self-management, and actively cooperating with treatment are crucial for disease prognosis. Healthcare providers must enhance patient education and clinical competencies while strictly adhering to diagnostic and therapeutic guidelines for comprehensive cLBP management. Policymakers and academic organizations should focus on developing evidence-based clinical guidelines, strengthening healthcare system oversight, and promoting widespread implementation of standardized cLBP care protocols.
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 107-131
Open AccessA Chinese Guideline for the Diagnosis and Treatment of Chronic LOW Back Pain (2024 Edition)
Background: Low back pain (LBP) is the leading cause of disability worldwide, severely impairing patients' quality of life, consuming substantial healthcare resources, and increasing medical costs while reducing productivity. Low back pain has become the leading cause of disability worldwide and a major global public health issue. Objective: To enhance the ability of diagnosis and treatment for LBP to meet the needs of clinical diagnosis and treatment. Main ideas: Based on high quality evidence based medical research on the diagnosis and treatment of LBP published domestically and internationally between January 2010 and December 2023, the expert group of the Pain Disease Diagnosis and Treatment Special Capacity Enhancement Project of the National Health Commission of China's Capacity Building and Continuing Education Centerhas formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of LBP. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common chronic specific low back pain (cSLBP) and chronic non-specific low back pain (cNSLBP). Conclusion: LBP is characterized by high prevalence, significant disability rates, and frequent recurrence, imposing substantial burdens on individuals, families, and society. For patients, improving understanding of cLBP, practicing effective self-management, and actively cooperating with treatment are crucial for disease prognosis. Healthcare providers must enhance patient education and clinical competencies while strictly adhering to diagnostic and therapeutic guidelines for comprehensive cLBP management. Policymakers and academic organizations should focus on developing evidence-based clinical guidelines, strengthening healthcare system oversight, and promoting widespread implementation of standardized cLBP care protocols.
- Open Access
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 56-86
A Chinese Guideline for the Diagnosis and Treatment of Neuropathic Pain
Background : Neuropathic pain refers to pain caused by injury or disease affecting the somatosensory nervous system, which is a common and frequently occurring disease in clinical practice, and seriously affects patients' quality of life. However, the treatment of neuropathic pain is a clinical challenge. Objective : To standardize neuropathic pain management, the Pain Medicine Branch of China Association of Health Care for the Elderly convened an expert panel to develop the guideline. Main ideas : Based on high quality evidence-based medical research on the diagnosis and treatment of neuropathic pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of neuropathic pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common peripheral neuropathic pain and central neuropathic pain. Chinese traditional medicine also plays an important role in the treatment of neuropathic pain, so this guide also provides Chinese traditional medicine drugs and treatment recommendations. Conclusion : The Chinese pain community has proposed the principle of "treatment forward, early intervention, prevention of sensitization, and prevention and treatment of chronic pain", which has played a positive role in improving the clinical diagnosis and treatment level of neuropathic pain.
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 56-86
Open AccessA Chinese Guideline for the Diagnosis and Treatment of Neuropathic Pain
Background : Neuropathic pain refers to pain caused by injury or disease affecting the somatosensory nervous system, which is a common and frequently occurring disease in clinical practice, and seriously affects patients' quality of life. However, the treatment of neuropathic pain is a clinical challenge. Objective : To standardize neuropathic pain management, the Pain Medicine Branch of China Association of Health Care for the Elderly convened an expert panel to develop the guideline. Main ideas : Based on high quality evidence-based medical research on the diagnosis and treatment of neuropathic pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of neuropathic pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common peripheral neuropathic pain and central neuropathic pain. Chinese traditional medicine also plays an important role in the treatment of neuropathic pain, so this guide also provides Chinese traditional medicine drugs and treatment recommendations. Conclusion : The Chinese pain community has proposed the principle of "treatment forward, early intervention, prevention of sensitization, and prevention and treatment of chronic pain", which has played a positive role in improving the clinical diagnosis and treatment level of neuropathic pain.
- Open Access
- 9 April 2020
- Published by Wiley in Pain Research and Management
- Vol. 2020, 1-4
Pain Vision System for Evaluating Chronic Pain: A Comparison with VAS Scoring
Objective. To study the value of pain vision system in quantitative evaluation of chronic pain from the perspective of neuroelectrophysiology, as compared with VAS (visual analog scale). Methods. Seventy-one patients with chronic pain were randomly selected to receive pain treatments from August 1, 2018, to September 30, 2018, in the Pain Department of Li Zhuang Tongji Hospital. Among all patients, 26 had cervical spondylosis and 45 had lumbar disc herniation. Pain vision and visual analog scoring (VAS) were used to evaluate the degree of pain before and after treatment. The correlation between the pain vision system’s pain ratio (pain ratio) and the VAS score was analyzed. Results. Pain ratio and VAS scores were linearly correlated before and after treatment in patients with chronic pain (Pearson coefficient was 0.730 before treatment and 0.449 after treatment; ). Conclusions. The pain vision system can evaluate chronic pain well and quantify it in the form of pain degree, which is helpful for objective quantitative analysis of chronic pain. This trial is registered with ChiCTR1900026331.- 9 April 2020
- Published by Wiley in Pain Research and Management
- Vol. 2020, 1-4
Open AccessPain Vision System for Evaluating Chronic Pain: A Comparison with VAS Scoring
Objective. To study the value of pain vision system in quantitative evaluation of chronic pain from the perspective of neuroelectrophysiology, as compared with VAS (visual analog scale). Methods. Seventy-one patients with chronic pain were randomly selected to receive pain treatments from August 1, 2018, to September 30, 2018, in the Pain Department of Li Zhuang Tongji Hospital. Among all patients, 26 had cervical spondylosis and 45 had lumbar disc herniation. Pain vision and visual analog scoring (VAS) were used to evaluate the degree of pain before and after treatment. The correlation between the pain vision system’s pain ratio (pain ratio) and the VAS score was analyzed. Results. Pain ratio and VAS scores were linearly correlated before and after treatment in patients with chronic pain (Pearson coefficient was 0.730 before treatment and 0.449 after treatment; ). Conclusions. The pain vision system can evaluate chronic pain well and quantify it in the form of pain degree, which is helpful for objective quantitative analysis of chronic pain. This trial is registered with ChiCTR1900026331.